Biosimilars: How Much Entry and Price Competition Will Result?

Adrian Towse

Monograph from Office of Health Economics

Abstract: This publication reports on a seminar intended to encourage further thought about the distinguishing characteristics of the market for biosimilars and the implications of these for potential savings. Economists and regulatory experts from the US and Europe were invited to describe their research and offer their perspectives about what can be expected in the near- and medium-term. The publication includes updated insights that take account of changes since the seminar, including more recent analyses of potential market impact. Chapter authors include Profs Bengt Jönsson (Stockholm School of Economics), Prof Henry Grabowski (Duke University), Prof Adrian Towse and Dr. Jorge Mestre-Ferrandiz (OHE), Prof Richard G. Frank (Harvard Medical School / US Department of Health and Human Services), Dr. Gopalan Narayanan (UK MHRA Biologicals and Technology Unit), Dr. Matthias Liefner (Simon Kucher) and Alexis Ahlstrom (Avalere Health / US Department of Health and Human Services).

Keywords: Biosimilars:; How; Much; Entry; and; Price; Competition; Will; Result? (search for similar items in EconPapers)
JEL-codes: I1 (search for similar items in EconPapers)
Date: 2010-12-01
References: Add references at CitEc
Citations: View citations in EconPapers (4)

Downloads: (external link)
https://www.ohe.org/publications/biosimilars-how-m ... uch-entry-and-price/ (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ohe:monogr:000195

Access Statistics for this paper

More papers in Monograph from Office of Health Economics Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).